TI
CTMX icon

Trexquant Investment’s CytomX Therapeutics CTMX Stock Holding History

Trexquant Investment’s Portfolio CTMX Stock Details CTMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-898,767
Closed -$4.22M – 1945
2026
Q1 		$4.22M Buy
+898,767
New +$4.56M 0.03% 718
2021
Q2 		– Sell
-13,810
Closed -$107K – 1158
2021
Q1 		$107K Sell
13,810
-6,403
-32% -$50.7K 0.01% 1051
2020
Q4 		$132K Sell
20,213
-57,550
-74% -$411K 0.01% 949
2020
Q3 		$517K Sell
77,763
-50,511
-39% -$375K 0.03% 666
2020
Q2 		$1.07M Buy
128,274
+109,863
+597% +$1.02M 0.07% 376
2020
Q1 		$141K Buy
+18,411
New +$128K 0.01% 1017
2019
Q4 		– Sell
-12,855
Closed -$95K – 1066
2019
Q3 		$95K Buy
12,855
+1,213
+10% +$12K 0.01% 813
2019
Q2 		$131K Sell
11,642
-20,888
-64% -$219K 0.01% 728
2019
Q1 		$350K Buy
+32,530
New +$481K 0.02% 695
2018
Q3 		– Sell
-19,670
Closed -$450K – 981
2018
Q2 		$450K Sell
19,670
-4,648
-19% -$119K 0.03% 568
2018
Q1 		$692K Buy
+24,318
New +$694K 0.05% 525
2017
Q4 		– Sell
-26,110
Closed -$474K – 1076
2017
Q3 		$474K Buy
+26,110
New +$407K 0.12% 293
2017
Q2 		– Sell
-60,979
Closed -$1.05M – 845
2017
Q1 		$1.05M Buy
60,979
+44,079
+261% +$580K 0.14% 236
2016
Q4 		$186K Buy
+16,900
New +$205K 0.03% 843

Other funds holding CTMX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Trexquant Investment's CTMX Position: Q2 2026 in Review

Trexquant Investment sold out of CytomX Therapeutics (CTMX) in Q2 2026, closing a stake of 898,767 shares — an estimated $4.22M sold.

Trexquant Investment first reported a position in CTMX in Q4 2016 and held it in 14 quarters. The position peaked at $4.22M in Q1 2026. 179 funds tracked by Wall St. Rank hold CTMX as of Q2 2026.

  • Trexquant Investment reported no remaining CytomX Therapeutics position as of Q2 2026 after selling out during the quarter.
  • Trexquant Investment sold 898,767 CytomX Therapeutics shares in Q2 2026, an estimated $4.22M.
  • Trexquant Investment first reported a position in CytomX Therapeutics in Q4 2016 and held it in 14 quarters.
  • Trexquant Investment's CytomX Therapeutics position peaked at $4.22M in Q1 2026.
  • 179 funds tracked by Wall St. Rank held CytomX Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.